{"has_more":false,"total_items":10,"itemsCrossref":[{"issue":1,"VG_ID":0,"published_date":2021,"journal":"Journal of Financial Economics","volume":139,"page_from":109,"title":"Common ownership and competition in product markets","authors":[{"author_name":"Andrew Koch"},{"author_name":"Marios Panayides"},{"author_name":"Shawn Thomas"}],"doi":"https://doi.org/10.1016/j.jfineco.2020.07.007"}],"info_icon_message":"<div><b>Definition of Citations:</b><br><div align=left>This link gives the references of papers that cite this paper that have been resolved by SSRNs automated systems, with hot links to online versions of each paper where we have been able to locate them.","itemsSSRN":[{"reference_info":"Tuck School of Business Working Paper No. 3285161","posted_date":"10 Dec 2018","authors":[{"author_name":"Joseph Gerakos","author_url":"https://papers.ssrn.com/sol3/cf_dev/AbsByAuth.cfm?per_id=342413"},{"author_name":"Jin Xie","author_url":"https://papers.ssrn.com/sol3/cf_dev/AbsByAuth.cfm?per_id=1745352"}],"fullTextUrl":"https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3354295_code1745352.pdf?abstractid=3285161","revised_date":"9 Jun 2021","ssrn_abstract_id":3285161,"VG_ID":1093357,"abstract_url":"https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3285161","title":"Institutional Horizontal Shareholdings and Generic Entry in the Pharmaceutical Industry","in_myLibrary":0,"downloads":"      361","pdf_pages":83,"is_fee":false,"doi":"https://doi.org/10.2139/ssrn.3285161"},{"reference_info":"","posted_date":"29 Jun 2020","authors":[{"author_name":"Jin Xie","author_url":"https://papers.ssrn.com/sol3/cf_dev/AbsByAuth.cfm?per_id=1745352"}],"fullTextUrl":"","ssrn_abstract_id":3619675,"VG_ID":1208089,"abstract_url":"https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3619675","title":"The Social Costs of Portfolio Diversification: Evidence from Patent Challenges in the Pharmaceutical Industry","in_myLibrary":0,"downloads":"        0","pdf_pages":0,"is_fee":false,"doi":"https://doi.org/10.2139/ssrn.3619675"}]}